Home Medicine Stability of lactate dehydrogenase in plasma at different temperatures: post-analytical storage
Article Open Access

Stability of lactate dehydrogenase in plasma at different temperatures: post-analytical storage

A translation of this article can be found here: https://doi.org/10.1515/almed-2020-0025
  • Marta Gómez López EMAIL logo , Neila Rodríguez Roca , Manuela Simón Velasco , María José Alcaide Martín , Antonio Buño Soto and Rubén Gómez Rioja ORCID logo
Published/Copyright: October 7, 2020

To the Editor,

Sample storage conditions are crucial to pre-analytical and post-analytical storage in clinical laboratories. Samples are routinely refrigerated during the post-analytical phase. Refrigeration reduces cellular metabolism and diminishes degradation reactions in a large number of analytes, although it may not be an optimal storage condition for other. Such is the case of lactate dehydrogenase (LDH), although consensus about the optimal temperature of storage for LDH remains elusive. In this context, a study was performed according to the protocol published by the Spanish Society for Laboratory Medicine (SEQCML) [1] to determine the limit of stability for LDH in plasma stored both at room temperature (RT) and refrigerated.

In a preliminary study, determinations were performed at baseline and at the established analysis times, which coincided with usual post-analytical storage times in our laboratory. The maximum allowable difference (MAD) was established according to laboratory quality standards (6.39%, minimum systematic error calculated using the BV formula provided in the SEQCML database) [2].

For such purpose, the surplus of three lithium heparin plasma samples was employed. Each sample was split into three aliquots: a baseline aliquot was stored at −80 °C immediately after collection (baseline sample), whereas the other aliquots were stored at RT and at 4–8 °C. After 48 h, all aliquots were stored at −80 °C. Then, samples were thawed, homogenized and analyzed in the same run. Following IFCC guidelines, LDH activity was determined by the lactate:pyruvate method in a Dimension Vista 1500 analyzer (Siemens Healthineers). Determinations were performed in sextuplicate considering the ratio between MAD and the usual analytical imprecision in our laboratory (CV=2.97%).

Loss of stability was expressed as the percentage difference (%PD) among replicate measurements in each sample calculated by the formula %PD=Ttime−Tbasal/Tbasal*100. No significant variations were observed at room temperature (%PD < MAD). In contrast, a 12–15% loss exceeding MAD was observed in refrigerated samples (Table 1).

Table 1:

Summary of preliminary study results.

Patient 1 Patient 2 Patient 3
Baseline Room temperature Refrigerated Baseline Room temperature Refrigerated Baseline Room temperature Refrigerated
Mean 591.83 611.50 518.00 242.67 248.33 211.67 259.17 251.83 219.00
SD 9.83 16.47 3.22 3.20 5.16 3.44 1.47 1.33 3.52
%CV 1.66 2.69 0.62 1.32 2.08 1.63 0.57 0.53 1.61
%PD 3.32 −12.48 2.34 −12.77 −2.83 −15.50
MAD% 6.39% 6.39% 6.39% 6.39% 6.39% 6.39%
  1. PD, percentage difference; MAD, maximum allowable difference.

An extended study was performed to calculate the limit of stability under refrigeration. For such purpose, 10 samples of plasma were split into seven aliquots that corresponded to each time studied: baseline, 12, 24, 36, 48, 60 and 72 h, which were stored at 4–8 °C. The aliquots that had been stored in a refrigerator were frozen at −80 °C at each time studied. After the established time, all aliquots were thawed, homogenized and analyzed in a single run in duplicate.

An instability equation (%PD=−0.14*time (h)) adjusted using the least squares method was designed. Pearson’s correlation coefficient (R) was 0.87 and a gradient far from 0 was obtained. This equation shows a daily loss of stability of 3.4%. In other words, for a MAD of 6.39%, the limit of stability was 45 h (Figure 1).

Figure 1: 
Graphic representation of the extended study.
Figure 1:

Graphic representation of the extended study.

The results of our study are consistent with the ones obtained by Shimizu Y, An B and Heins M [3], [4], [5], who reported that activity decreases in refrigerated samples, whereas it remains stable at RT. In contrast, Oddoze C [6] observed an increased activity. Limits of stability ranged from 1 to 4 days, which can be explained by different MAD criteria, which ranged from 3.53 to 7%.

The loss of stability of LDH under refrigeration could be caused by the different thermosensitivity of LDH isoenzymes. LDH-4 and 5 are especially labile and are likely to be the elements responsible for the loss of activity under refrigeration [4]. This could also explain the substantial between-subject variability observed. The different thermosensitivity of LDH isoenzymes may explain that the three patients included in the preliminary study exhibited a greater loss of stability than predicted by the extended model, which included a higher number of patients.

The information available about the stability of biochemical analytes is often confusing. Verification of stability limits in each laboratory guarantees that the limit of stability is adjusted to the specific conditions of each laboratory, such as the type of tube, temperature, light or shaking. The preliminary study proposed by SEQCML allows laboratories to confirm the validity of a usual stability limits, adapted to routine laboratory practice in a straightforward and cost-effective way. In case a potential loss of stability is detected, an extended study will allow to calculate an equation of instability that can be shared with other laboratories that work in similar conditions.


Corresponding author: Marta Gómez López, Laboratory Medicine Department, La Paz University Hospital, Paseo de la Castellana 261, 28046 Madrid, Spain, E-mail:

  1. Article Note: The original article can be found here: https://doi.org/10.1515/almed-2020-0025

  2. Research funding: None declared.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Competing interests: Authors state no conflict of interest.

  5. Informed consent: Informed consent was obtained from all individuals included in this study.

  6. Ethical approval: This research study was performed in accordance with the principles of the Declaration of Helsinki (2013 update), as well as with national and local laws and regulations and was approved by the Institutional Review Board or similar board.

References

1. Gómez-Rioja, R, Segovia Amaro, M, Díaz-Garzón, J, Bauçà, JM, Martínez Espartosa, D, Fernández-Calle, P. A protocol for testing the stability of biochemical analytes. Technical document. Clin Chem Lab Med 2019;0:1829–36. https://doi.org/10.1515/cclm-2019-0586.Search in Google Scholar PubMed

2. SECQML. Base de datos de variación biológica de la Comisión de Calidad Analítica. Disponible en http://www.seqc.es/es/comisiones/comision-decalidad-analitica/_id:4/.Search in Google Scholar

3. Shimizu, Y, Ichihara, K. Elucidation of stability profiles of common chemistry analytes in serum stored at six graded temperatures. Clin Chem Lab Med 2019;57:1388–96. https://doi.org/10.1515/cclm-2018-1109.Search in Google Scholar PubMed

4. Heins, M, Heil, W, Withold, W. Storage of serum or whole blood samples? Effects of time and temperature on 22 serum analytes. Clin Chem Lab Med 1995;33:231–8. https://doi.org/10.1515/cclm.1995.33.4.231.Search in Google Scholar PubMed

5. An, B, Park, C-E. Evaluation of stability of serum on different storage temperatures for routine chemistry analytes. Korean J Clin Lab Sci 2014;46:111–6. https://doi.org/10.15324/kjcls.2014.46.4.111.Search in Google Scholar

6. Oddoze, C, Lombard, E, Portugal, H. Stability study of 81 analytes in human whole blood, in serum and in plasma. Clin Biochem[Internet] 2012;45:464–9. https://doi.org/10.1016/j.clinbiochem.2012.01.012.Search in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/almed-2020-0077).


Received: 2020-02-10
Accepted: 2020-03-25
Published Online: 2020-10-07

© 2020 Marta Gómez López et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Editorial
  2. Brief update on coronavirus disease 2019 (COVID-19) diagnostics
  3. Breve actualización sobre el diagnóstico de la enfermedad por coronavirus 2019 (COVID-19)
  4. Challenges of COVID-19
  5. Retos de la COVID-19
  6. Review / Artículo de Revisión
  7. SARS-CoV-2: a new threat
  8. SARS-CoV-2: una nueva amenaza
  9. VALIDA project: Validation of allergy in vitro diagnostics assays (Tools and recommendations for the assessment of in vitro tests in the diagnosis of allergy)
  10. Proyecto VALIDA: Validation of ALlergy In vitro Diagnostics Assays (Herramientas y recomendaciones para la valoración de las pruebas in vitro en el diagnóstico de la alergia)
  11. Original Article / Artículo Original
  12. Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
  13. Evaluación del papel de diversos biomarcadores en el desarrollo de eventos cardiovasculares adversos mayores en pacientes sometidos a cirugía cardíaca
  14. CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value
  15. El CYFRA 21-1 en pacientes con sospecha de cáncer: evaluación de un punto de corte óptimo para evaluar la eficacia diagnóstica y el valor pronóstico
  16. Lactose tolerance test as an alternative to hydrogen breath test in the study of lactose malabsorption
  17. Estudio del test de tolerancia a lactosa como alternativa a test de hidrógeno espirado en el estudio de la malabsorción de lactosa
  18. Precision and trueness verification study of an Atellica system
  19. Estudio de verificación de precisión y veracidad en un sistema Atellica
  20. Case Report / Caso Clínico
  21. A variant of the gene HARS detected in the clinical exome: etiology of a peripheral neuropathy undiagnosed for 20 years
  22. Variante en gen HARS detectada en exoma clínico: etiología de neuropatía periférica tras más de 20 años sin diagnóstico
  23. Letter to the Editor / Carta al Editor
  24. Stability of lactate dehydrogenase in plasma at different temperatures: post-analytical storage
  25. Estudio de la estabilidad de la actividad lactato deshidrogenasa en plasma a distintas temperaturas: conservación post-analítica
Downloaded on 17.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/almed-2020-0077/html
Scroll to top button